FMP
Chemomab Therapeutics Ltd.
CMMB
NASDAQ
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
0.669 USD
-0.0315 (-4.71%)
About
ceo
Dr. Adi Mor George Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.chemomab.com
exchange
NASDAQ
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.
CIK
0001534248
ISIN
US16385C1045
CUSIP
03280X102
Address
Building 7
Phone
972 77 331 0156
Country
IL
Employee
20
IPO Date
Feb 12, 2019
Summary
CIK
0001534248
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
03280X102
ISIN
US16385C1045
Country
IL
Price
0.67
Beta
-0.04
Volume Avg.
227.66k
Market Cap
9.5M
Shares
-
52-Week
0.42-1.89
DCF
0.76
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.32
P/B
-
Website
https://www.chemomab.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CMMB News
It looks like there's no news available.
